KRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
KORU Medical Systems, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$3.02+0.02 (+0.67%)
Close on Oct 19, 2026
- Market cap
- $149.52M
- P/E (TTM)
- –
- Dividend yield
- –
KORU Medical Systems, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $8.40M | $8.44M | $8.31M | $6.71M | $8.01M | $7.21M | $7.32M | $7.02M | $6.78M | $6.38M | $5.78M | $5.93M | 69.7% | +4.8% |
| Non-US [Member] | $3.65M | $3.33M | $2.58M | $3.70M | $2.18M | $2.43M | $1.52M | $1.16M | $1.65M | $1.81M | $1.41M | $1.07M | 30.3% | +67.2% |
From the segment and revenue-disaggregation notes of KORU Medical Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.